ESOPMay 18, 2026, 04:03 PM
Cytokinetics Grants Equity Awards to 8 New Employees
AI Summary
Cytokinetics announced it granted equity awards to 8 new employees who commenced employment in April and May 2026. These awards include stock options to purchase 20,807 shares of common stock and 13,793 restricted stock units (RSUs). The grants serve as a material inducement for their employment, aligning with Nasdaq listing rules.
Key Highlights
- Cytokinetics granted stock options for 20,807 shares of common stock to 8 new employees.
- The company granted 13,793 restricted stock units (RSUs) to 8 new employees.
- Stock options have an exercise price of $75.85 per share, equal to the May 15, 2026 closing price.
- Stock options vest over 4 years, with 1/4th after one year and monthly thereafter for 36 months.
- RSUs vest over 3 years: 40% on the first anniversary, 40% on the second, and 20% on the third.
- Awards were granted as material inducements to employment, per Nasdaq Listing Rule 5635(c)(4).
Price Impact
More from CYTK